Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arpi Minassian

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Psychopharmacology|May 1, 2012
A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitationKai MacDonald, Michael Wilson, Arpi Minassian, et al.
The International Journal of Neuropsychopharmacology|August 2, 2021
HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced DeficitsBenjamin Z Roberts, Arpi Minassian, Adam L Halberstadt, et al.
Psychiatry Research|August 2, 2014
Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioningErin E Morgan, Katie L Doyle, Arpi Minassian, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 2018
Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviorsMolly A Kwiatkowski, Gerhard Hellemann, Catherine A Sugar, et al.
Neuropharmacology|August 5, 2017
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across speciesZackary A Cope, Arpi Minassian, Dustin Kreitner, et al.
Bipolar Disorders|April 27, 2019
Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPTJared W Young, Mark A Geyer, Adam L Halberstadt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 29, 2022
Deriving psychiatric symptom-based biomarkers from multivariate relationships between psychophysiological and biochemical measuresDaniel M Stout, Alan N Simmons, Caroline M Nievergelt, et al.
Addictive Behaviors|July 14, 2019
Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunctionMariana Cherner, Caitlin W-M Watson, Rowan Saloner, et al.
International Psychogeriatrics|November 21, 2008
Reduction of suboptimal prescribing and clinical outcome for dementia patients in a senior behavioral health inpatient unitVirginia T Chan, Benjamin K P Woo, Daniel D Sewell, et al.
Drug and Alcohol Dependence|September 2, 2020
Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependenceNina Pocuca, Jared W Young, David A MacQueen, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Psychopharmacology|May 1, 2012
A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitationKai MacDonald, Michael Wilson, Arpi Minassian, et al.
The International Journal of Neuropsychopharmacology|August 2, 2021
HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced DeficitsBenjamin Z Roberts, Arpi Minassian, Adam L Halberstadt, et al.
Psychiatry Research|August 2, 2014
Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioningErin E Morgan, Katie L Doyle, Arpi Minassian, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 2018
Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviorsMolly A Kwiatkowski, Gerhard Hellemann, Catherine A Sugar, et al.
Neuropharmacology|August 5, 2017
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across speciesZackary A Cope, Arpi Minassian, Dustin Kreitner, et al.
Bipolar Disorders|April 27, 2019
Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPTJared W Young, Mark A Geyer, Adam L Halberstadt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 29, 2022
Deriving psychiatric symptom-based biomarkers from multivariate relationships between psychophysiological and biochemical measuresDaniel M Stout, Alan N Simmons, Caroline M Nievergelt, et al.
Addictive Behaviors|July 14, 2019
Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunctionMariana Cherner, Caitlin W-M Watson, Rowan Saloner, et al.
International Psychogeriatrics|November 21, 2008
Reduction of suboptimal prescribing and clinical outcome for dementia patients in a senior behavioral health inpatient unitVirginia T Chan, Benjamin K P Woo, Daniel D Sewell, et al.
Drug and Alcohol Dependence|September 2, 2020
Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependenceNina Pocuca, Jared W Young, David A MacQueen, et al.
Pageof 10